We can readily understand why investors are attracted to unprofitable companies. By way of example, Microbot Medical (NASDAQ:MBOT) has seen its share price rise 142% over the last year, delighting ...

Fintel reports that on November 28, 2025, HC Wainwright & Co. reiterated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 434.50% Upside As of ...

KUALA LUMPUR: Over 100,000 technologists and technicians including those specialising in emerging technologies are currently registered under the Malaysia Board of Technologists (MBOT), says Chang Lih ...

Microbot Medical Inc. (MBOT) has been beaten down lately with too much selling pressure. While the stock has lost 28.2% over the past four weeks, there is light at the end of the tunnel as it is now ...

HINGHAM, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of the innovative LIBERTY ® Endovascular Robotic System, announces that its Chief ...

HINGHAM, Mass. - Microbot Medical Inc. (NASDAQ:MBOT), a medical device company with a market capitalization of $205 million and showing strong momentum with a 20% gain last week, announced that CEO ...

MBOT’s main value driver is its LIBERTY robot. This is a disposable, portable endovascular robot that has great potential. LIBERTY showed strong ACCESS-PVI data and now awaits FDA 510(k) clearance for ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Microbot Medical ( (MBOT)) has shared an ...

HINGHAM, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic System, announced it has been approved to receive a ...

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Microbot Medical today and set a price target of $9.00. The company’s shares closed last Friday at $2.62. According to TipRanks, ...